期刊文献+

HAEG方案治疗难治性急性白血病的疗效

Effects of HAEG Regimen on Refractory Acute Leukemia
下载PDF
导出
摘要 目的探讨HAEG方案治疗难治性白血病的疗效。方法高三尖杉酯碱( Har)1 mg/d ,第1 ~10天;阿糖胞苷(Ara-C)30 mg/d ,第1 ~14天;足叶乙甙(VP-16)50 mg/d ,第1 ~5天;粒细胞集落刺激因子(G-CSF)150μg/d ,第1 ~14天,组成HAEG方案,治疗15例难治性急性白血病,观察疗效。结果完全缓解8例(53 .3 %) ,部分缓解2例(13 .4 %) ,总有效率为66 .7 %。结论 HAEG方案治疗难治性急性白血病有一定的疗效。 Objective To explore the therapeutic protocol for refractory acute leukemia. Methods Fifteen cases of refractory acute leukemia were treated with HAEG regimen, which consisted of Hat1 mg/d(dl-10),Ara-C 30 mg/d(dl-14),VP-16 50 mg/d(dl-5),G-CSF 150 mg/d (d1-14). Results Eight patients (53.3%) achieved complete remission, 2 (13.4%)did partial remission, overall effective rate was 66.7%. Conclusion HAEG regimen in treatment of refractory acute leukemia is an effective means.
出处 《实用临床医学(江西)》 CAS 2008年第5期34-35,共2页 Practical Clinical Medicine
关键词 HAEG方案 粒细胞集落刺激因子 难治性急性白血病 HAEG regimen granunocyte cloning stimulatory factor refractory acute leukemia
  • 相关文献

参考文献5

  • 1吴德沛,傅琤琤,唐晓文,孙爱宁,马骁,苗瞄,刘跃,均张日,夏学鸣.含有大剂量阿糖胞苷的联合化疗治疗难治和复发急性白血病[J].中华血液学杂志,2004,25(11):696-697. 被引量:32
  • 2Harouseau J L,Wu D P. The Use of GM-CSF and G-CSF in the Treatment of Acute Leukemia[J]. Leuk Lymphoma,1995, 18 : 405-412.
  • 3Amuguleng B,Hiroshi K,Mitsuo H,et al. Priming with G-CSF Effectively Enhances Low-dose Ara-C-induced in Vivo Apoptosis in Myeloid Leukemia Cells[J]. Exp Hematol, 1999,27 : 259- 265.
  • 4Katagiri T, Myazawa K, Nishimaki J, et al. Combination of Granulocyte Colony-stimulating Factor and Low-dose Cytosine Arabinoside Further Enhances Myeloid Differentiation in Leukemia Cells in Vito[J]. Leuk Lymphoma, 2000,39: 173- 184.
  • 5孙雨梅,吕德晖,张彦明.AAG预激化疗方案治疗急性白血病疗效分析[J].徐州医学院学报,2007,27(8):533-534. 被引量:5

二级参考文献6

  • 1吴学宾,高雪芝,金宝翠,陈宝安,黄晓明,高峰.鬼臼乙叉甙诱导HL-60细胞凋亡作用的实验研究[J].中华血液学杂志,1996,17(12):651-652. 被引量:27
  • 2Harousseau JL,Wu DP.The use of GM-CSF and G-CSF in the treatment of acute leukemias[J].Leuk Lymphoma,1995,18(5-6):405 -412.
  • 3Bai A,Kojima H,Hori M,et al.Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells[J].Exp Hematol,1999,27 (2):259-265.
  • 4KaranesC,KopeckyKJ,HeadDR ,etal.AphaseⅢcomparisonofhighdoseARA C (HIDAC)versusHIDACplusmitoxantroneinthetreatmentoffirstreplasedorrefractoryacutemyeloidleukemiaSouthwestOncologyGroupStudy[].LeukRes.1999
  • 5SteinAS,O’DonnellMR,SlovakML ,etal.High dosecytosinearabinosideanddaunorubicininductiontherapyforadultpatientswithdenovononM3acutemyelogenousleukemia:impactofcytoge neticsonachievingacompleteremission[].Leukemia.2000
  • 6Creutzig U,Ritter J,Zimmermann M,et al.Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93[].Journal of Clinical Oncology.2001

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部